Skip to content

Development and evaluation of diagnostic biomarker panels on the basis of microarray analysis for treatment planning of oral squamous cell carcinoma

Development and evaluation of diagnostic biomarker panels on the basis of microarray analysis for treatment planning of oral squamous cell carcinoma - Biomarker Panel

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00000199
Enrollment
80
Registered
2011-01-13
Start date
2009-04-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oral squamous cell carcinoma

Interventions

Group 1: tissue sample

Sponsors

Pro Inno II AiF Projekt GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: histologically diagnosed squamous cell carcinoma of the oral cavity, no adjuvant therapy

Exclusion criteria

Exclusion criteria: inoperability, tumour entities other than squamous cell carcinoma

Design outcomes

Primary

MeasureTime frame
The aim of our study is to develop a biomarker panel on the basis of gene expression anlysis by microarray technique. With the information of the altered gene expression of few selected marker genes a precise diagnosis, prognosis and individually adapted therapy regimen will be established. The requirement for this biomolecular diagnostic tool is to be reliable, cost-efficient, quick and sensitive. The microarray analysis of the collected samples is carried out at the moment with special softwear and not finished yet.

Secondary

MeasureTime frame
One aim of our project was to develop a simple and economic device to diagnose and categorize the oral squamous cell carcinoma on the basis of clinical data combined with genetic alterations.

Countries

Germany

Contacts

Public ContactJohannes Kleinheinz

Klinik für Mund-, Kiefer- und Gesichtschirurgie

Johannes.Kleinheinz@ukmuenster.de00492518347001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026